| |
Δ Discounted DALYS relative to baseline |
Δ Discounted Costs ($ millions) relative to baseline |
Ratio of $ saved (-) or $ spent (+) to DALYs averted or incurred. Positive ratios are Incremental Cost Effectiveness Ratio (ICER) $ per DALY averted. |
| Bangladesh |
Mean |
SD |
Mean |
SD |
Median |
Interquartile Range |
Notes |
| Stop SIAs (SS) |
2.34E+06 |
9.09E+05 |
-44 |
(7) |
-$19 |
(-14: |
-28.9) |
[1] |
| 95% Reduction by 2015 |
-1.88E+06 |
4.71E+05 |
61 |
(4) |
$34 |
(26: |
44) |
|
| 98% Reduction by 2020 |
-1.78E+06 |
4.95E+05 |
74 |
(5) |
$42 |
(33: |
54) |
|
| Eradication 2020 (E2020) |
-1.96E+06 |
4.50E+05 |
156 |
(4) |
$81 |
(67: |
102) |
|
| Eradication 2025 (E2025) |
-1.96E+06 |
4.52E+05 |
164 |
(4) |
$85 |
(70: |
108) |
|
| Eradication 2020 & Stop MCV2 |
-1.97E+06 |
4.49E+05 |
71 |
(4) |
$36 |
(29: |
48) |
|
| Eradication 2025 & Stop MCV2 |
-1.94E+06 |
4.46E+05 |
102 |
(4) |
$55 |
(43: |
68) |
|
| Ethiopia |
|
|
|
|
|
|
|
|
|
|
| Stop SIAs (SS) |
1.05E+07 |
1.69E+06 |
-26 |
(5) |
-$3 |
(2.0: |
3.1) |
[1] |
| 95% Reduction by 2015 |
-4.38E+06 |
1.14E+06 |
197 |
(4) |
$43 |
(38: |
56) |
|
| 98% Reduction by 2020 |
-4.63E+06 |
1.17E+06 |
394 |
(4) |
$86 |
(72: |
107) |
|
| Eradication 2020 (E2020) |
-6.03E+06 |
1.01E+06 |
534 |
(3) |
$91 |
(78: |
101) |
|
| Eradication 2025 (E2025) |
-5.74E+06 |
1.20E+06 |
644 |
(4) |
$112 |
(96: |
132) |
|
| Eradication 2020 & Stop MCV2 |
-6.07E+06 |
1.07E+06 |
376 |
(4) |
$64 |
(54: |
71) |
|
| Eradication 2025 & Stop MCV2 |
-5.94E+06 |
9.82E+05 |
506 |
(3) |
$86 |
(76: |
97) |
|
| Uganda |
|
|
|
| Stop SIAs (SS) |
5.09E+06 |
9.00E+05 |
-7 |
(4) |
-$1 |
(-2: |
-.8) |
[1] |
| 95% Reduction by 2015 |
-2.15E+06 |
6.48E+05 |
154 |
(3) |
$72 |
(59: |
90.5) |
|
| 98% Reduction by 2020 |
-2.37E+06 |
6.49E+05 |
281 |
(3) |
$119 |
(100: |
147) |
|
| Eradication 2020 (E2020) |
-3.34E+06 |
5.63E+05 |
393 |
(3) |
$118 |
(106: |
135) |
|
| Eradication 2025 (E2025) |
-3.26E+06 |
5.40E+05 |
478 |
(3) |
$147 |
(133: |
167) |
|
| Eradication 2020 & Stop MCV2 |
-3.29E+06 |
6.08E+05 |
293 |
(3) |
$89 |
(78: |
103) |
|
| Eradication 2025 & Stop MCV2 |
-3.25E+06 |
5.69E+05 |
383 |
(3) |
$119 |
(106: |
134) |
|
| Brazil |
|
|
|
| Eradication 2020 (E2020) |
-9.29E+01 |
6.80E+01 |
-41 |
(.6) |
-$432,000 |
(-280,000: |
-630,000) |
[2] |
| Eradication 2025 (E2025) |
-6.80E+01 |
7.10E+01 |
-31 |
(.6) |
-$394,000 |
(-227,000: |
-658,000) |
|
| Eradication 2020 & Stop MCV2 |
-9.96E+01 |
5.54E+01 |
-68 |
(.6) |
-$748,000 |
(-510,000: |
-1,043,000) |
|
| Eradication 2025 & Stop MCV2 |
-7.54E+01 |
6.54E+01 |
-52 |
(.6) |
-$646,000 |
(-391,000: |
-1,175,000) |
|
| Colombia |
|
|
|
|
|
|
|
|
|
|
| Eradication 2020 (E2020) |
-3.30E+02 |
5.41E+02 |
-12 |
(3) |
-$70,000 |
(-37,000: |
-92,600) |
[2] |
| Eradication 2025 (E2025) |
-2.97E+02 |
5.46E+02 |
-9 |
(3) |
-$58,000 |
(-27,100: |
-87,100) |
|
| Eradication 2020 & Stop MCV2 |
-3.28E+02 |
5.42E+02 |
-21 |
(3) |
-$122,000 |
(-62,800: |
-169,700) |
|
| Eradication 2025 & Stop MCV2 |
-3.05E+02 |
5.46E+02 |
-16 |
(3) |
-$103,000 |
(-43,500: |
-146,000) |
|
| Tajikistan |
|
|
|
|
|
|
|
|
|
|
| Eradication 2020 (E2020) |
-9.63E+03 |
3.15E+03 |
14 |
(1) |
$1,500 |
(1,900: |
1,200) |
[2] |
| Eradication 2025 (E2025) |
-6.45E+03 |
3.00E+03 |
12 |
(1) |
$1,800 |
(2,800: |
1,400) |
|
| Eradication 2020 & Stop MCV2 |
-9.74E+03 |
2.71E+03 |
9 |
(1) |
$1,000 |
(1,300: |
800) |
|
| Eradication 2025 & Stop MCV2 |
-7.06E+03 |
2.78E+03 |
9 |
(1) |
$1,300 |
(1,800: |
900) |
|
| [1] Stop SIAs option is cost saving, but increases the DALY burden |
| [2] Eradication options in Brazil, Colombia, and Tajikistan save money and lower DALY burden. ICER column gives ratio in which these benefits accumulate |
| Baseline Levels |
Bangladesh |
Ethiopia |
Uganda |
Brazil |
Colombia |
Tajikistan |
|
| Discounted DALYS |
1.9 M |
6.3 M |
3.5 M |
131 |
325 |
11.4K |
|
| Discounted Costs |
$170M |
$157M |
$94M |
$192M |
$55M |
$15M |
|
|
